Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1957 (Rev 10/2011) |
OMB No. 0651-0050 (Exp 09/20/2020) |
Response to Office Action
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
88087526 |
LAW OFFICE ASSIGNED |
LAW OFFICE 119 |
MARK SECTION |
MARK |
http://uspto.report/TM/88087526/mark.png |
LITERAL ELEMENT |
NUCLEOPRIME |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
MARK STATEMENT |
The mark consists of standard characters, without claim to any particular font style, size or color. |
GOODS AND/OR SERVICES SECTION (current) |
INTERNATIONAL CLASS |
001 |
DESCRIPTION |
Nucleotide/Nucleotides, derivatives of Nucleotide/Nucleotides including salts, polymers, esters, acids, Nucleotide/Nucleotides isomers,
and derivatives of Nucleotide/Nucleotides isomers including salts, polymers, esters, acids used as raw materials in food, nutrition and/or dietary supplement industries |
FILING BASIS |
Section 1(a) |
FIRST USE ANYWHERE DATE |
At least as early as 02/01/2018 |
FIRST USE IN COMMERCE DATE |
At least as early as 02/01/2018 |
GOODS AND/OR SERVICES SECTION (proposed) |
INTERNATIONAL CLASS |
001 |
TRACKED TEXT DESCRIPTION |
Nucleotide/Nucleotides, derivatives of Nucleotide/Nucleotides including salts, polymers, esters, acids,
Nucleotide/Nucleotides isomers, and derivatives of Nucleotide/Nucleotides isomers including salts, polymers, esters, acids used as raw materials in food, nutrition and/or dietary supplement
industries; raw materials in the nature of nucleotides and nucleotides derivatives in the form of salts, polymers, esters, acids, and nucleotides isomers, for use
in the manufacture of nutritional and dietary supplements. |
FINAL DESCRIPTION |
raw materials in the nature of nucleotides and nucleotides derivatives in the form of salts, polymers, esters, acids, and nucleotides
isomers, for use in the manufacture of nutritional and dietary supplements. |
FILING BASIS |
Section 1(a) |
FIRST USE ANYWHERE DATE |
At least as early as 02/01/2018 |
FIRST USE IN COMMERCE DATE |
At least as early as 02/01/2018 |
SIGNATURE SECTION |
RESPONSE SIGNATURE |
/Wu Xianxi/ |
SIGNATORY'S NAME |
Wu Xianxi |
SIGNATORY'S POSITION |
Principal |
DATE SIGNED |
01/22/2019 |
AUTHORIZED SIGNATORY |
YES |
FILING INFORMATION SECTION |
SUBMIT DATE |
Tue Jan 22 03:30:02 EST 2019 |
TEAS STAMP |
USPTO/ROA-XX.XX.XX.XXX-20
190122033002635602-880875
26-620c8ea46957eea2e8cd1c
04fab118ec6185d5c229db93b
d2b76a2d419668b-N/A-N/A-2
0190122032509472766 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1957 (Rev 10/2011) |
OMB No. 0651-0050 (Exp 09/20/2020) |
Response to Office Action
To the Commissioner for Trademarks:
Application serial no.
88087526 NUCLEOPRIME(Standard Characters, see http://uspto.report/TM/88087526/mark.png) has been amended as follows:
CLASSIFICATION AND LISTING OF GOODS/SERVICES
Applicant proposes to amend the following class of goods/services in the application:
Current: Class 001 for Nucleotide/Nucleotides, derivatives of Nucleotide/Nucleotides including salts, polymers, esters, acids, Nucleotide/Nucleotides isomers, and derivatives of
Nucleotide/Nucleotides isomers including salts, polymers, esters, acids used as raw materials in food, nutrition and/or dietary supplement industries
Original Filing Basis:
Filing Basis: Section 1(a), Use in Commerce: The applicant is using the mark in commerce, or the applicant's related company or licensee is using the mark in commerce, on or in connection with
the identified goods and/or services. 15 U.S.C. Section 1051(a), as amended. The mark was first used at least as early as 02/01/2018 and first used in commerce at least as early as 02/01/2018 , and
is now in use in such commerce.
Proposed:
Tracked Text Description: Nucleotide/Nucleotides, derivatives of Nucleotide/Nucleotides including salts, polymers, esters, acids, Nucleotide/Nucleotides isomers,
and derivatives of Nucleotide/Nucleotides isomers including salts, polymers, esters, acids used as raw materials in food, nutrition and/or dietary supplement industries;
raw materials in the nature of nucleotides and nucleotides derivatives in the form of salts, polymers, esters, acids, and nucleotides isomers, for use in the manufacture of nutritional
and dietary supplements.Class 001 for raw materials in the nature of nucleotides and nucleotides derivatives in the form of salts, polymers, esters, acids, and nucleotides isomers, for use in
the manufacture of nutritional and dietary supplements.
Filing Basis: Section 1(a), Use in Commerce: The applicant is using the mark in commerce, or the applicant's related company or licensee is using the mark in commerce, on or in connection with
the identified goods and/or services. 15 U.S.C. Section 1051(a), as amended. The mark was first used at least as early as 02/01/2018 and first used in commerce at least as early as 02/01/2018 , and
is now in use in such commerce.
SIGNATURE(S)
Response Signature
Signature: /Wu Xianxi/ Date: 01/22/2019
Signatory's Name: Wu Xianxi
Signatory's Position: Principal
The signatory has confirmed that he/she is not represented by either an authorized attorney or Canadian attorney/agent, and that he/she is either: (1) the owner/holder ; or (2) a person(s) with legal
authority to bind the owner/holder; and if an authorized U.S. attorney or Canadian attorney/agent previously represented him/her in this matter, either he/she has filed a signed revocation of power
of attorney with the USPTO or the USPTO has granted the request of his/her prior representative to withdraw.
Serial Number: 88087526
Internet Transmission Date: Tue Jan 22 03:30:02 EST 2019
TEAS Stamp: USPTO/ROA-XX.XX.XX.XXX-20190122033002635
602-88087526-620c8ea46957eea2e8cd1c04fab
118ec6185d5c229db93bd2b76a2d419668b-N/A-
N/A-20190122032509472766